RNVU1-3
gene geneOn this page
Also known as vU1.3RNU1-113vU1.12RNU1-151
Summary
RNVU1-3 (RNA, variant U1 small nuclear 3, HGNC:48311) is a small nuclear RNA gene on chromosome 1q21.1.
Predicted to enable pre-mRNA 5’-splice site binding activity. Predicted to be involved in mRNA 5’-splice site recognition. Predicted to be part of U1 snRNP.
Source: NCBI Gene 101954272 — RefSeq curated summary.
At a glance
- Gene type: non-coding (snRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48311 |
| Approved symbol | RNVU1-3 |
| Name | RNA, variant U1 small nuclear 3 |
| Location | 1q21.1 |
| Locus type | RNA, small nuclear |
| Status | Approved |
| Aliases | vU1.3, RNU1-113, vU1.12, RNU1-151 |
| Ensembl gene | ENSG00000201183 |
| Ensembl biotype | snRNA |
| Entrez | 101954272 |
| RNAcentral | URS000075CD30 — snRNA, 161 nt, 2 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 snRNA
ENST00000364313
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000364313 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001808668 | 148402715 | 148402875 |
Expression profiles
Bgee: expression breadth ubiquitous, 117 present calls, max score 92.52.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9528 / max 104.2428, expressed in 490 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201698 | 1.9528 | 490 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| superior frontal gyrus | UBERON:0002661 | 92.52 | gold quality |
| monocyte | CL:0000576 | 85.39 | gold quality |
| bone marrow | UBERON:0002371 | 81.07 | gold quality |
| sural nerve | UBERON:0015488 | 80.46 | gold quality |
| prefrontal cortex | UBERON:0000451 | 79.07 | gold quality |
| primary visual cortex | UBERON:0002436 | 78.52 | gold quality |
| right uterine tube | UBERON:0001302 | 77.25 | gold quality |
| blood | UBERON:0000178 | 76.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 76.57 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.01 | gold quality |
| endocervix | UBERON:0000458 | 74.93 | gold quality |
| adenohypophysis | UBERON:0002196 | 74.92 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.82 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 73.98 | gold quality |
| pituitary gland | UBERON:0000007 | 73.75 | gold quality |
| ectocervix | UBERON:0012249 | 73.51 | gold quality |
| cerebellar cortex | UBERON:0002129 | 73.41 | gold quality |
| cerebellum | UBERON:0002037 | 73.37 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 73.26 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.91 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 72.47 | gold quality |
| corpus callosum | UBERON:0002336 | 72.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.16 | gold quality |
| endometrium | UBERON:0001295 | 71.98 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.86 | gold quality |
| urinary bladder | UBERON:0001255 | 71.00 | gold quality |
| right lung | UBERON:0002167 | 70.84 | gold quality |
| left uterine tube | UBERON:0001303 | 70.74 | gold quality |
| right ovary | UBERON:0002118 | 70.66 | gold quality |
| lymph node | UBERON:0000029 | 70.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (147): RNU1-75P (ENSG00000194297), RNU1-15P (ENSG00000195024), RNU1-58P (ENSG00000199283), RNU1-150P (ENSG00000199361), RNU1-108P (ENSG00000199426), RNU1-62P (ENSG00000199469), RNU1-70P (ENSG00000199488), RNU1-94P (ENSG00000199497), RNU1-14P (ENSG00000199629), RNU1-35P (ENSG00000199652), RNU1-38P (ENSG00000199687), RNU1-76P (ENSG00000199773), RNU1-134P (ENSG00000199805), RNU1-47P (ENSG00000199836), RNU1-72P (ENSG00000199846), RNVU1-22 (ENSG00000199879), RNU1-17P (ENSG00000199892), RNU1-18P (ENSG00000199932), RNU1-19P (ENSG00000200176), RNU1-20P (ENSG00000200184), RNU1-21P (ENSG00000200197), RNU1-22P (ENSG00000200204), RNU1-23P (ENSG00000200231), RNU1-83P (ENSG00000200296), RNU1-49P (ENSG00000200338), RNU1-105P (ENSG00000200340), RNVU1-33 (ENSG00000200597), RNU1-124P (ENSG00000200731), RNU1-31P (ENSG00000200745), RNU1-65P (ENSG00000200789), RNU1-130P (ENSG00000200800), RNU1-32P (ENSG00000200807), RNU1-146P (ENSG00000200885), RNU1-42P (ENSG00000200903), RNU1-7P (ENSG00000200975), RNVU1-34 (ENSG00000200997), RNU1-96P (ENSG00000201033), RNU1-33P (ENSG00000201119), RNU1-151P (ENSG00000201142), RNU1-24P (ENSG00000201155)
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.